Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Isoprenaline hydrochloride；NCI-c55630;Isoprenaline HCl;Isoproterenol hydrochloride | C11H18ClNO3 | 51-30-9 | Details |
| BLM-IN-1 | C28H35FN4O | 2056014-40-3 | Details |
| BJE6-106；B106 | C26H23NO2 | 1564249-38-2 | Details |
| BKI-1369 | C23H27N7O | 1951431-22-3 | Details |
| (4-Acetamidocyclohexyl) nitrate；BM121307 | C8H14N2O4 | 137213-91-3 | Details |
| BM-131246 | C22H20N2O4S | 103787-97-9 | Details |
| BM635 | C25H29FN2O | 1493762-74-5 | Details |
| (8R,9S)-Talazoparib；(8R,9S)-BMN-673 | C19H14F2N6O | 1207456-00-5 | Details |
| BMS-1001 hydrochloride | C35H35ClN2O7 | 2113650-04-5 | Details |
| BMY-43748 | C20H17F3N4O3 | 132195-65-4 | Details |
| BM 957 | C52H56ClF3N6O7S3 | 1391107-54-2 | Details |
| BMVC | C28H25IN3+ | 627810-06-4 | Details |
| BMY-25271 | C12H19N5O2S2 | 78441-82-4 | Details |
| BMT-124110 | C21H27N3O3 | 1679371-59-5 | Details |
| BMT-145027 | C23H14ClF3N4 | 2018282-44-3 | Details |
| BMS-901715 | C22H28N10O | 1699861-37-4 | Details |
| Azilsartan；TAK-536 | C25H20N4O5 | 147403-03-0 | Details |
| Fostemsavir Tris；BMS-663068 Tris | C29H37N8O11P | 864953-39-9 | Details |
| BMS-470539 dihydrochloride | C32H42ClN5O4 | 2341796-82-3 | Details |
| BMS-654457 | C36H37N5O4 | 1004551-41-0 | Details |
| BMS-191095 | C22H21ClN4O2 | 166095-21-2 | Details |
| BMS-214662 | C25H23N5O2S2 | 195987-41-8 | Details |
| BOC-D-FMK | C11H18FNO5 | 634911-80-1 | Details |
| Borrelidin；Treponemycin | C28H43NO6 | 7184-60-3 | Details |
| Bovinic acid | C18H32O2 | 2540-56-9 | Details |
| Bozitinib；CBT-101;PLB-1001 | C20H15F3N8 | 1440964-89-5 | Details |
| BPH-1358 free base；NSC50460 free base | C32H28N6O2 | 801985-13-7 | Details |
| BPH-1358；NSC50460 | C32H29ClN6O2 | 5352-53-4 | Details |
| BPH-652 | C16H16K3O7PS | 157124-84-0 | Details |
| BPI-9016M | C25H18F2N4O3 | 1528546-94-2 | Details |
| BPN-15606 | C23H23FN6O | 1914989-49-3 | Details |
| Retinyl palmitate；Retinyl (Vitamin A) Palmitate;Vitamin A palmitate;Retinol palmitate | C36H60O2 | 79-81-2 | Details |
| Zatolmilast；BPN14770 | C21H15ClF3NO2 | 1606974-33-7 | Details |
| BPO-27 racemate；BPO-27 (racemate) | C26H18BrN3O6 | 1314873-02-3 | Details |
| BPR1M97 | C18H18Cl2N2O | 2059904-66-2 | Details |
| bpV(phen) | C12H8KN2O5V | 42494-73-5 | Details |
| BQ-788 | C34H51N5O7 | 173326-37-9 | Details |
| BQ-788 sodium salt | C34H52N5NaO7 | 156161-89-6 | Details |
| BR102375 | C31H34N6O4 | 2366255-59-4 | Details |
| BR351 | C20H25FN2O5S | 960113-85-3 | Details |
| BO3482 | C14H20N2NaO5S2 * | 198013-53-5 | Details |
| Carboplatin；JM-8;CBDCA;NSC 241240 | C6H12N2O4Pt | 41575-94-4 | Details |
| Ticarcillin disodium；Ticarcillin disodium salt;Ticarpen | C15H17N2NaO6S2 | 4697-14-7 | Details |
| Btk inhibitor 2；BGB-3111 analog | C24H25N5O3 | 1558036-85-3 | Details |
| BTK inhibitor 13 | C29H26FN5O3 | 2376726-26-8 | Details |
| BSc5371 | C24H31N5O4S | 2286419-03-0 | Details |
| BT-13 | C23H27F4N3O4S | 924537-98-4 | Details |
| IBT6A | C22H22N6O | 1022150-12-4 | Details |
| IBT6A hydrochloride | C22H23ClN6O | 1553977-42-6 | Details |
| (Rac)-IBT6A | C22H22N6O | 1412418-47-3 | Details |
| BTK inhibitor 10 | C25H23N5O3 | 2241732-30-7 | Details |
| C-11 | C38H58N6O7S | 2007965-97-9 | Details |
| C-82 | C33H34N6O4 | 1422253-37-9 | Details |
| c-di-AMP；Cyclic diadenylate;Cyclic-di-AMP | C20H24N10O12P2 | 54447-84-6 | Details |
| c-Fms-IN-1 | C22H27N5O2 | 885703-64-0 | Details |
| c-Fms-IN-10 | C22H19N7OS | 1527517-50-5 | Details |
| c-Fms-IN-6 | C22H25N7O2 | 1628574-81-1 | Details |
| c-Fms-IN-7 | C26H24N6OS | 1313408-89-7 | Details |
| c-Fms-IN-8 | C27H30N2O5 | 1255303-58-2 | Details |
| c-Fms-IN-9 | C21H23N7O2 | 1628574-50-4 | Details |
| c-Fms-IN-3 | C23H30N6O | 885704-21-2 | Details |
| Baclofen；Lioresal | C10H12ClNO2 | 1134-47-0 | Details |
| c-Kit-IN-2 | C25H29N9O2S | 2121515-37-3 | Details |
| c-Kit-IN-3 | C26H20ClF3N2O4 | 2363169-01-9 | Details |
| BuChE-IN-TM-10；TM-10 | C32H38N2O3 | 2313524-95-5 | Details |
| Bucindolol | C22H25N3O2 | 71119-11-4 | Details |
| Bucolome；Paramidin;Paramidine | C14H22N2O3 | 841-73-6 | Details |
| Bumetanide-d5；Bumetanide D5 | C17H20N2O5S | 1216739-35-3 | Details |
| Bunaftide；Bunaphtide;Bunaftine;Meregon | C21H30N2O | 32421-46-8 | Details |
| Burixafor hydrobromide；TG-0054 hydrobromide | C27H52BrN8O3P | 1191450-19-7 | Details |
| 5α-reductase-IN-1 | C31H37NO5 | 119348-12-8 | Details |
| Butin | C15H12O5 | 21913-99-5 | Details |
| BY27 | C22H21ClN6 | 2247236-59-3 | Details |
| C-021 dihydrochloride | C27H42ClN5O2 | 1784252-84-1 | Details |
| Norepinephrine bitartrate monohydrate；Noradrenaline bitartrate monohydrate;Levophed | C12H17NO9 | 108341-18-0 | Details |
| BRCA1-IN-2 | C26H33N4O7P | 1622262-55-8 | Details |
| BRD 4354 | C21H23ClN4O | 315698-07-8 | Details |
| Flumequine；R-802;Flumigal | C14H12FNO3 | 42835-25-6 | Details |
| BRCA1-IN-1 | C27H33F2N4O6P | 1622262-74-1 | Details |
| BR351 precursor | C27H32N2O8S2 | 960113-89-7 | Details |
| BRAF inhibitor | C22H18F2N4O3S | 918505-61-0 | Details |
| BRD0705 | C20H23N3O | 2056261-41-5 | Details |
| BRD5648；(R)-BRD0705 | C20H23N3O | 2056261-42-6 | Details |
| BRD-K98645985 | C33H43N5O4 | 1357647-78-9 | Details |
| BRD-6929 | C19H17N3O2S | 849234-64-6 | Details |
| BRD-IN-3 | C21H25N5O3 | 2351938-32-2 | Details |
| Brevetoxin-3；PbTx-3 | C50H72O14 | 85079-48-7 | Details |
| Brexpiprazole-d8；OPC-34712 D8;Brexpiprazole D8 | C25H27N3O2S | 1427049-21-5 | Details |
| Toltrazuril；Baycox;Toltrazurilo;Toltrazurilum;BAY-i 9142 | C18H14F3N3O4S | 69004-03-1 | Details |
| BRL 37344 sodium；BRL 37344A | C19H23ClNNaO4 | 127299-93-8 | Details |
| Brexpiprazole S-oxide；DM-3411 | C25H27N3O3S | 1191900-51-2 | Details |
| BRL-42715 | C10H9N4NaO3S | 102209-75-6 | Details |
| BRL44385 | C8H11N5O3 | 114778-60-8 | Details |
| BRM/BRG1 ATP Inhibitor-1 | C11H9F3N4O2S | 2270879-17-7 | Details |
| Broflanilide | C25H14BrF11N2O2 | 1207727-04-5 | Details |
| Brofaromine；CGP 11305A | C14H16BrNO2 | 63638-91-5 | Details |
| Bromelain | N/A | 9001-00-7 | Details |
| Capsaicin；8-Methyl-N-vanillyl-trans-6-nonenamide;Qutenza;Zostrix;(E)-Capsaicin;Vanilloid | C18H27NO3 | 404-86-4 | Details |
| Bromodomain inhibitor-8 | C26H25ClN2O3 | 1300031-70-2 | Details |
| Bromodomain IN-1 | C22H23ClN4O3S | 1914120-48-1 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 | ||||